- Tytuł:
- AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
- Autorzy:
- Temat:
-
Isocitrate dehydrogenase 1
Peptide vaccine
Astrocytoma
Oligodendroglioma
Recurrent glioma
Window-of-opportunity
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429 - Źródło:
- Neurological Research and Practice, Vol 4, Iss 1, Pp 1-7 (2022)
- Opis pliku:
- electronic resource
- Relacje:
- https://doaj.org/toc/2524-3489
- Dostęp URL:
- https://doaj.org/article/4c9969cb47df44d0813e1eae513b7e2a  Link otwiera się w nowym oknie
Czasopismo naukowe